Stay updated with breaking news from Director Jacqualyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $39.70 and last traded at $38.91, with a volume of 573087 shares changing hands. The stock had previously closed at $31.50. Wall Street Analysts Forecast Growth A number of equities analysts have recently […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Equities researchers at Zacks Research increased their Q2 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research note issued to investors on Monday, May 20th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will earn ($1.59) per share for […]
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its target price raised by The Goldman Sachs Group from $29.00 to $33.00 in a report issued on Friday morning, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on AGIO. JPMorgan Chase & Co. reduced […]
Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) had its price target upped by The Goldman Sachs Group from $29.00 to $33.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s target price suggests a potential downside of 4.29% from […]
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price objective lowered by Royal Bank of Canada from $43.00 to $42.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the biopharmaceutical company’s stock. AGIO has been the subject of a number of other reports. The Goldman […]